肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2013年
7期
455-457
,共3页
秦丽%王承正%刘法文%律慧敏
秦麗%王承正%劉法文%律慧敏
진려%왕승정%류법문%률혜민
乳腺肿瘤,男性%生存分析%预后
乳腺腫瘤,男性%生存分析%預後
유선종류,남성%생존분석%예후
Breast neoplasms,male%Univariate analysis%Prognosis
目的 探讨男性乳腺癌的临床病理特点,分析影响预后的相关因素.方法 回顾59例男性乳腺癌患者资料,分析其临床病理特征及5年生存率,用生存分析方法探讨不同临床病理特征对生存的影响.结果 59例患者中位发病年龄为64岁,雌激素受体(ER)和(或)孕激素受体(PR)阳性率为74.6％(44/59).随访9～123个月,5年总生存率为61％,Ⅰ、Ⅱ期患者的生存明显优于Ⅲ、Ⅳ期患者.结论 男性乳腺癌有其独特的临床病理特点.TNM分期是影响预后的重要因素.
目的 探討男性乳腺癌的臨床病理特點,分析影響預後的相關因素.方法 迴顧59例男性乳腺癌患者資料,分析其臨床病理特徵及5年生存率,用生存分析方法探討不同臨床病理特徵對生存的影響.結果 59例患者中位髮病年齡為64歲,雌激素受體(ER)和(或)孕激素受體(PR)暘性率為74.6％(44/59).隨訪9～123箇月,5年總生存率為61％,Ⅰ、Ⅱ期患者的生存明顯優于Ⅲ、Ⅳ期患者.結論 男性乳腺癌有其獨特的臨床病理特點.TNM分期是影響預後的重要因素.
목적 탐토남성유선암적림상병리특점,분석영향예후적상관인소.방법 회고59례남성유선암환자자료,분석기림상병리특정급5년생존솔,용생존분석방법탐토불동림상병리특정대생존적영향.결과 59례환자중위발병년령위64세,자격소수체(ER)화(혹)잉격소수체(PR)양성솔위74.6％(44/59).수방9～123개월,5년총생존솔위61％,Ⅰ、Ⅱ기환자적생존명현우우Ⅲ、Ⅳ기환자.결론 남성유선암유기독특적림상병리특점.TNM분기시영향예후적중요인소.
Objective To investigate general and clinicopathological characteristics of male breast cancer and analyze the factors affecting the outcomes of the patients.Methods Fifty-nine male breast cancer patients treated at Cancer Hospital of Zhengzhou University from January 2002 to December 2011 were included into the study.The clinicopathologic features and 5-year survival rate were retrospectively analyzed.The clinicopathologieal characteristics were investigated by univariate analysis to evaluate the impact of these factors on patient survival.Results The median age at diagnosis was 64 years old in these patients.The positive rate of ER/PR was 74.6 ％ (44/59).The patients were followed up for 9-123 months.The 5-year survival rate was 61％.Patients in stages Ⅰ and Ⅱ had better overall survival than those in stages Ⅲ and Ⅳ.Conclusion The male breast cancer patient has special clinical characteristics.TNM stage is a significant predictor of the overall survival.
